COVERSE

Science | Education | Community | Advocacy

Donate
Shop

Research

If you are a researcher who is interested in working with COVID-19 vaccine-injured people, please contact us via research@coverse.org.au to discuss our research priorities.

There is an emerging body of research evidence around COVID-19 vaccine injuries. React19 maintains a list of 3,500+ of these publications.

Here are a few select publications and resources:

S-protein responsible for Long Covid and Long Vaccine Syndrome

The following review article summarises the leading theories, and makes the connection that both Long Covid and Long Vaccine Syndrome are triggered by the same S-protein found in SARS-CoV-2 and vaccines:

  • “The rationale for the treatment of long-Covid symptoms – A cardiologist’s view”, Frontiers in Cardiovascular Medicine, 15 September 2022, doi:10.3389/fcvm.2022.992686

And this next article delves a little deeper into potential biomolecular mechanisms leading to spike protein adverse events:

And in the case of Covid vaccines, evidence demonstrates that the S-protein may be persisting for an extremely long time within patients:

  • “Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms”, preprint, 24 March 2024, doi:10.1101/2024.03.24.24304286

Seeing the evidence of causality

The National Institute of Neurological Disorders and Stroke (NINDS) in the USA studied a group of vaccine-injured patients with significant neurological complications. Their investigations found clear evidence of causality.

(note: the authors’ claim that these patients have been successfully treated with corticosteroids and/or intravenous immunoglobulin is misleading, as most of the patients are still suffering ongoing symptoms more than a year after treatment)

Serious adverse events are not rare

In a reanalysis of the combined clinical trial data from Pfizer and Moderna, the following paper demonstrates that serious adverse events of special interest (AESI) may be occurring at a rate of at least 1-in-800:

  • “Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults”, Vaccine, 22 September 2022, doi:10.1016/j.vaccine.2022.08.036

Analysis of adverse event databases also indicates that the rate of adverse events is significantly higher for COVID-19 vaccines than the annual flu vaccine:

  • “Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States”, Frontiers in Public Health, 3 February 2022, doi:10.3389/fpubh.2021.756633.

And this Swiss study of hospital staff who received a booster suggests that the rate of myocardial injury may be dramatically greater than originally thought:

  • “Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination”, European Journal of Heart Failure, 20 July 2023, doi:10.1002/ejhf.2978.

Current studies

We try to keep up-to-date with current patient surveys and studies, and would appreciate any information you have on research that our community can participate in.

Scroll to top